|
|
Celiac Disease
Celiac disease is an immune mediated response to gluten that affects the gastrointestinal tract.1,2 Inherited factors make some individuals sensitive to a protein called gliadin, which is a part of the total protein or gluten found in grains. When undigested gluten reaches the small intestine, gliadin peptides activate auto-immune reactions in susceptible individuals.
Identifying Celiac Disease
It is estimated that more than 2 million people in the United States alone have celiac disease.4 The purpose of Metametrix new Celiac Profile is to accurately define those who are likely to have celiac disease. When IgA-tTG and IgA-AGA are positive, there is a high degree of certainty the patient has celiac disease. When IgA-tTG is positive with normal IgA-AGA, the patient may have celiac disease, but has followed a gluten-free diet, therefore reducing their IgA-AGA. Those individuals with moderate to strong positives may follow up with a biopsy.
1. NIH, N.I.o.H., NIH Consensus Development Conference on Celiac Disease. 2004 (June 28-30, 2004).
2. Thompson, T., Wheat starch, gliadin, and the gluten-free diet. J Am Diet Assoc, 2001. 101(12):p.1456-9.
3. Anderson, R., Coeliac Disease. Australian Family Physician, 2005. 34(4):p.239-242.
4. Westberg, D.P., et al., New Strategies for diagnosis and management of celiac disease. J Am Osteopath Assoc, 2006. 18(1):p.145-51.
|
|

Metametrix Celiac Profile
The celiac profile is composed of three tests:
- IgA human tissue transglutaminase (IgA-tTG): Occurs as an immune response to tissue transglutaminase and is rarely found in individuals without celiac disease.
- Serum IgA: Identifying serum IgA deficiencies are important for two reasons. First, IgA deficiencies can lead to false negatives for IgA-tTG. Second, individuals with an IgA deficiency have a 10 - 21 times greater risk of developing celiac disease.3
- IgA antigliadin antibody (IgA-AGA): This antibody develops against gliadin showing consumption of gluten-containing foods that can propagate the enteropathy of celiac disease.
|
|
Clinician Info
| Test name: |
0078- Celiac Profile - Serum
|
|
|
| Description: |
Celiac disease is an immune mediated response to gluten that affects the gastrointestinal tract. The celiac profile is composed of three tests: IgA human tissue translutaminase (IgA-tTG), Serum IgA, and IgA antigliadin antibody (IgA-AGA). The profile combines the three tests to accurately identify those likely to have celiac disease. |
|
|
| Method: |
ELISA and Immunoturbidometric assay |
|
|
| Turnaround time: |
6 - 8 days, 7 days average |
|
|
|
Antigens:
|
Anti-Gliadin IgA II Total Immunoglobulin A Transglutaminase antibody (IgA)
|
|
CPT codes:
| 83516 x2 |
- |
| Gliadin IgA / Anti-Gliadin IgA II |
| 82784 |
- |
| IgA |
|
The PDF should now automatically load in another browser window.
If the PDF has not yet loaded, please click link below:
|
| |
|
|
Update on the evaluation and diagnosis of Celiac disease.
Leffler, D.A. and C.P. Kelly. Curr Opin Allergy Clin Immunol, 2006. 6(3): p. 191-6.
New strategies for diagnosis and management of Celiac disease.
Westerberg, D.P., et al., J Am Osteopath Assoc, 2006. 106(3): p. 145-51.
Celiac sprue (the great modern-day imposter).
Lee, S.K. and P.H. Green. Curr Opin Rheumatol, 2006. 18(1): p. 101-7.
Celiac disease as a cause of iron deficiency anemia.
Sabel'nikova, E.A., et al., Ter Arkh, 2006. 78(2): p. 45-8.
Dermatitis herpetiformis and partial IgA deficiency.
Samolitis, N.J., et al., J Am Acad Dermatol, 2006. 54(5 Suppl): p. S206-9.
Duration of exposure to gluten and risk for autoimmune disorders in patients with Celiac disease.
Ventura, A., G. Magazzu, and L. Greco. SIGEP Study Group for Autoimmune Disorders in Celiac Disease.
Gastroenterology, 1999. 117(2): p. 297-303.
Current approaches to diagnosis and treatment of Celiac disease: an evolving spectrum.
Fasano, A. and C. Catassi. Gastroenterology, 2001. 120(3): p. 636-51.
Performance of antibodies against tissue transglutaminase for the diagnosis of Celiac disease: meta-analysis.
Zintzaras, E. and A.E. Germenis. Clin Vaccine Immunol, 2006. 13(2): p. 187-92.
Comparative studies of different gliadin preparations in detecting antigliadin antibodies
Kumar, V., et al. J Pediatr Gastroenterol Nutr, 1986. 5(5): p. 730-4.
Does cryptic gluten sensitivity play a part in neurological illness?
Hadjivassiliou, M., et al., Lancet, 1996. 347(8998): p. 369-71.
Celiac disease: a diverse clinical syndrome caused by intolerance of wheat, barley and rye.
McGough, N. and J.H. Cummings. Proc Nutr Soc, 2005. 64(4): p. 434-50.
|
|